Therapeutic Targeting of DNA Damage Repair in the Era of Precision Oncology and Immune Checkpoint Inhibitors

Medicine and Dentistry

• DNA Repair 100%
• DNA Damage Response 100%
• Immune Checkpoint Inhibitor 100%
• Precision Oncology 100%
• Malignant Neoplasm 83%
• Immunotherapy 50%
• Carcinogenesis 33%
• Cancer Control 16%
• Immune Response 16%
• DNA Damage 16%
• Neoplasm 16%
• Cancer Treatment 16%
• Personalized Medicine 16%
• Genomic Instability 16%
• Tumor 16%
• PARP Inhibitor 16%
• Tumor Immune Microenvironment 16%
• Cell Free Nucleic Acid 16%

Immunology and Microbiology

• DNA Damage Response 100%
• DNA Repair 100%
• Immune Checkpoint Inhibitor 100%
• Immunotherapy 50%
• Immune Response 16%
• DNA Damage 16%
• Genomic Instability 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Immune Checkpoint Inhibitor 100%
• Malignant Neoplasm 100%
• Immunotherapy 42%
• Neoplasm 28%
• Carcinogenesis 28%
• Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase Inhibitor 14%
• Cell Free Nucleic Acid 14%
• Gene Delivery 14%